New light-based imaging for centronuclear myopathy
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study tests a new type of imaging that uses light and sound to look at muscles in people with centronuclear myopathy. It may help doctors see muscle changes more clearly. It does not involve any treatment or medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with centronuclear myopathy
- You are at least 2 years old
- You are not pregnant or nursing
- You do not have a tattoo on the part of the body being examined
- The fat under your skin in the exam area is not thicker than 3 cm
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with congenital myopathies to understand how their muscles get tired over time. It may help develop better treatments.
This trial is testing a new, non-invasive imaging technique called MSOT to look at head and neck tumors. It compares images from people with tumors to healthy volunteers, aiming to improve how doctors evaluate tissue before surgery.
This study tests whether new imaging techniques (called MSOT and ULM) can better see vascular malformations. It may help doctors diagnose and understand these conditions without the need for risky procedures.
This study uses a special imaging machine (MSOT) to look at different types of swelling in the legs, such as lipedema and lymphedema. It aims to help doctors better understand and tell these conditions apart.
This study uses a safe, non-invasive light test (called MSOT) to help diagnose and monitor children with muscle or nerve diseases. It aims to find better ways to track these conditions without needles or radiation.
This study uses MRI scans to measure muscle changes in people with myotonic dystrophy (DM1 or DM2) and healthy volunteers. The goal is to find better ways to track the disease over time.
Hear when a new Centronuclear Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.